Composition Tuning of Semi-Open Cell Carriers via Phase Freeze-Shrink Self-Molding
Source abstract
Abstract
Extracellular matrix (ECM)-mimicking microsized cell carriers featuring a semi-isolated chamber facilitate the study of cellular heterogeneity as well as intercellular communication. However, the semiopen shaping of the designated gel mixture remains unattainable with current methods. We report an oil-phase freeze-shrink self-molding mechanism for generating size- and composition-tunable cradle-shaped microgels (microcradles) from water-in-oil droplets. The universality of this shape transition principle is demonstrated with six types of polysaccharides dispersed in a poly(ethylene glycol) diacrylate (PEGDA) or methacrylate gelatin (GelMA) matrix. By doping the microcradles with the major ECM component, hyaluronic acid sodium, we demonstrate a label-free selective culture of CD44 receptor-rich cells and the formation of cell spheroids within 3 days. This cryo-induced cradle-shaping strategy enables the functionalization of microcarriers for selective cell culture, thereby allowing them to be used for intercellular communication, drug delivery, and the construction of structural units for osteogenesis and 3D printing.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Viral Infectious Diseases and Gene Expression in Insects · 3D Printing in Biomedical Research · Silk-based biomaterials and applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Chemistry, College of Sciences, Northeastern University, Shenyang 110819, China
Funding
Liaoning Revitalization Talents Program · Fundamental Research Funds for the Central Universities · National Natural Science Foundation of China
References (35)
Show source-provided references
1. 10.1002/smll.20210775710.1002/smll.202107757 ↗
2. 10.1016/j.cis.2020.10223710.1016/j.cis.2020.102237 ↗
3. 10.1016/j.biomaterials.2017.06.02010.1016/j.biomaterials.2017.06.020 ↗
4. 10.1016/j.carbpol.2020.11634510.1016/j.carbpol.2020.116345 ↗
5. 10.1002/smll.20220018010.1002/smll.202200180 ↗
6. 10.1039/b809915b10.1039/b809915b ↗
7. 10.1021/acsnano.1c1142010.1021/acsnano.1c11420 ↗
8. 10.1002/anie.20181137410.1002/anie.201811374 ↗
9. 10.1002/anie.20200503410.1002/anie.202005034 ↗
10. 10.1002/smll.20110271510.1002/smll.201102715 ↗
11. 10.1002/anie.20200970110.1002/anie.202009701 ↗
12. 10.1002/smll.20180109510.1002/smll.201801095 ↗
13. 10.1002/smll.20190656510.1002/smll.201906565 ↗
14. 10.1021/acsnano.1c0585710.1021/acsnano.1c05857 ↗
15. 10.1016/j.cej.2022.13927710.1016/j.cej.2022.139277 ↗
16. 10.1016/j.matpr.2020.12.92210.1016/j.matpr.2020.12.922 ↗
17. 10.3390/jfb1401002310.3390/jfb14010023 ↗
18. 10.1016/j.biomaterials.2013.01.07710.1016/j.biomaterials.2013.01.077 ↗
19. 10.1186/1471-2121-5-1010.1186/1471-2121-5-10 ↗
20. 10.1002/(SICI)1097-4652(199611)169:2<341::AID-JCP13>3.0.CO;2-C10.1002/(SICI)1097-4652(199611)169:2<341::AID-JCP13>3.0.CO;2-C ↗
21. 10.1002/eji.183025022810.1002/eji.1830250228 ↗
22. 10.1016/j.carbpol.2019.11578710.1016/j.carbpol.2019.115787 ↗
23. 10.1016/j.biomaterials.2013.03.06510.1016/j.biomaterials.2013.03.065 ↗
24. Novák J. · Anticancer Res. · 2005 · 25 · 1157
25. 10.1016/j.tibtech.2012.12.00310.1016/j.tibtech.2012.12.003 ↗
26. 10.1038/s41565-023-01401-710.1038/s41565-023-01401-7 ↗
27. 10.1159/00045283810.1159/000452838 ↗
28. 10.1002/adma.20230018010.1002/adma.202300180 ↗
29. 10.1016/j.actbio.2020.05.02410.1016/j.actbio.2020.05.024 ↗
30. 10.1016/j.bioactmat.2022.09.02010.1016/j.bioactmat.2022.09.020 ↗
31. 10.1038/s41467-022-35140-510.1038/s41467-022-35140-5 ↗
32. 10.1002/anie.20221286610.1002/anie.202212866 ↗
33. 10.1016/j.biomaterials.2020.12045810.1016/j.biomaterials.2020.120458 ↗
34. 10.1016/j.actbio.2022.01.04710.1016/j.actbio.2022.01.047 ↗
35. 10.1016/j.microc.2023.10863510.1016/j.microc.2023.108635 ↗